Literature DB >> 15345111

Subjective and objective risk of breast cancer in Ashkenazi Jewish individuals at risk for BRCA1/2 mutations.

Kimberly Kelly1, Howard Leventhal, Monica Marvin, Deborah Toppmeyer, Judith Much, James Dermody, Jill Baran, Marvin Schwalb.   

Abstract

The aims of the study were to (1) examine the differences between subjective and objective estimates of the risk of breast cancer in those being tested for BRCA1/2 mutations, (2) explore new ways to conceptualize risk, and (3) examine the change in subjective risk of developing breast cancer throughout the process of genetic counseling and testing. Participants were 86 Ashkenazi Jewish women with a family or personal history indicating risk for BRCA1/2 mutations. Surveys to assess subjective risk of breast cancer (percentage risk, projected age of onset, and survival time) were administered before counseling, after counseling, and after receipt of test results. Subjective percentage risk of breast cancer was compared to estimated objective risk to determine accuracy. Those with no personal history of cancer receiving positive results became more accurate from post-counseling to post-result. Those receiving positive results increased their estimate of their percentage risk, and those receiving uninformative negative results decreased their estimate of their percentage risk from post-counseling to post-result. Those without a personal history of cancer decreased in perceived risk from post-counseling to post-result. No change in projected age of onset of breast cancer or survival time with breast cancer was seen from pre- to post-counseling or from post-counseling to post-result, and no change in accuracy or in percentage risk of breast cancer was seen from pre- to post-counseling. Individuals use information from genetic counseling to form estimates of percentage risk following receipt of test results; however, projected age of onset and survival time with breast cancer, areas not targeted by genetic counseling that may be more closely linked to health behavior, do not change.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15345111     DOI: 10.1089/gte.2004.8.139

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  10 in total

1.  Health behaviors among Ashkenazi Jewish individuals receiving counseling for BRCA1 and BRCA2 mutations.

Authors:  Jackie Quach; Kyle Porter; Howard Leventhal; Kimberly M Kelly
Journal:  Fam Cancer       Date:  2009-01-28       Impact factor: 2.375

2.  What does risk of future cancer mean to breast cancer patients?

Authors:  Karen Kaiser; Kenzie A Cameron; Jennifer Beaumont; Sofia F Garcia; Leilani Lacson; Margaret Moran; Lindsey Karavites; Chiara Rodgers; Swati Kulkarni; Nora M Hansen; Seema A Khan
Journal:  Breast Cancer Res Treat       Date:  2019-03-06       Impact factor: 4.872

3.  Linking genetic counseling content to short-term outcomes in individuals at elevated breast cancer risk.

Authors:  Kimberly M Kelly; Lee Ellington; Nancy Schoenberg; Parul Agarwal; Thomas Jackson; Stephanie Dickinson; Jame Abraham; Electra D Paskett; Howard Leventhal; Michael Andrykowski
Journal:  J Genet Couns       Date:  2014-03-28       Impact factor: 2.537

4.  Genetic counseling content: How does it impact health behavior?

Authors:  Kimberly M Kelly; Lee Ellington; Nancy Schoenberg; Thomas Jackson; Stephanie Dickinson; Kyle Porter; Howard Leventhal; Michael Andrykowski
Journal:  J Behav Med       Date:  2014-12-23

5.  Cancer recurrence worry, risk perception, and informational-coping styles among Appalachian cancer survivors.

Authors:  Kimberly M Kelly; Randi Shedlosky-Shoemaker; Kyle Porter; Philip Desimone; Michael Andrykowski
Journal:  J Psychosoc Oncol       Date:  2011

6.  Closing the loop: an interactive action-research conference format for delivering updated medical information while eliciting Latina patient/family experiences and psychosocial needs post-genetic cancer risk assessment.

Authors:  Deborah J Macdonald; Julia Deri; Charité Ricker; Martin A Perez; Raquel Ogaz; Nancy Feldman; Lori A Viveros; Benjamin Paz; Jeffrey N Weitzel; Kathleen R Blazer
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

7.  Subjective versus objective risk in genetic counseling for hereditary breast and/or ovarian cancers.

Authors:  Anita Caruso; Cristina Vigna; Bruna Marozzo; Fabio M Sega; Isabella Sperduti; Francesco Cognetti; Antonella Savarese
Journal:  J Exp Clin Cancer Res       Date:  2009-12-21

8.  Perceived risk of breast cancer among Latinas attending community clinics: risk comprehension and relationship with mammography adherence.

Authors:  Kristi D Graves; Elmer Huerta; Jennifer Cullen; Elizabeth Kaufman; Vanessa Sheppard; George Luta; Claudine Isaacs; Marc D Schwartz; Jeanne Mandelblatt
Journal:  Cancer Causes Control       Date:  2008-08-15       Impact factor: 2.506

9.  Cancer family history reporting: impact of method and psychosocial factors.

Authors:  Kimberly M Kelly; Randi Shedlosky-Shoemaker; Kyle Porter; Amber Remy; Philip DeSimone; Michael A Andrykowski
Journal:  J Genet Couns       Date:  2007-02-23       Impact factor: 2.717

10.  Network Modeling of Complex Time-Dependent Changes in Patient Adherence to Adjuvant Endocrine Treatment in ER+ Breast Cancer.

Authors:  Eileen H Shinn; Brooke E Busch; Neda Jasemi; Cole A Lyman; J Tory Toole; Spencer C Richman; William Fraser Symmans; Mariana Chavez-MacGregor; Susan K Peterson; Gordon Broderick
Journal:  Front Psychol       Date:  2022-07-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.